TREATMENT OF UROGENITAL INFECTIONS DURING PREGNANCY
Keywords:
Key words: urogenital infections, bacterial vaginosis, pregnancyAbstract
Annotation: Urogenital infections (UGI) remain one of the urgent problems of obstetrics and gynecology. During gestation, UGI can cause complications such as chorioamnionitis, delayed intrauterine development and intrauterine and intranatal infection of the fetus, spontaneous miscarriages, premature birth, purulent-septic complications in the postpartum period. According to the literature, UGI in pregnant women is highly common and often occurs in a latent form, complicating their timely diagnosis and subsequent treatment.
References
1. Prilepskaya V.N. Vulvovaginal candidiasis: clinic, diagnosis, principles of therapy. Moscow: GEOTAR-Media, 2010. 80c.
2. Mendling W, Brasch J. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society. Mycoses, 2012, 55(3): 1-13.
3. Kira E.F. Modern approaches to the choice of a local drug in the treatment of bacterial vaginosis. Obstetrics and Gynecology, 2012, 7:59-67.
4. Donders G., Bellen G., Rezeberga D. Aerobic vaginitis in pregnancy. BJOG, 2011, 118(10): 1163-70.
5. Ermolenko D.K., Isakov V.A., Rybalkin S.B., Smirnova T.S., Zakharkiv Yu.F. Urogenital trichomoniasis: A manual for doctors. Urogenital trichomoniasis: A manual for doctors. St. Petersburg: Veliky Novgorod, 2007. 96 p.
6. Buchta V, Spacek J. Pitfalls of the current laboratory diagnosis and treatment of vulvovaginal candidiasis. Klin. Mikrobiol. Infekc. Lek., 2011, 17(5): 158-63.
7. Ilkit M, Guzel AB. The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective. Crit Rev Microbiology, 2011, 37(3): 250-61.
8. Roberts CL, Rickard K, Kotsiou G, Morris JM. Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open-label pilot randomized controlled trial. BMC Pregnancy Childbirth, 2011, 11: 18.
9. Stock I. Fungal diseases of vulva and vagina caused by Candida species. Med. Monatsschr. Pharm., 2010, 33(9): 324-33.
10. Del-Cura GI, Garcia-de-Blas GF. Patient preferences and treatment safety for uncomplicated vulvovaginal candidiasis in primary health care. PRESEVAC project. BMC Public Health, 2011, 31(11): 63-65.
11. Fardiazar Z, Ronaci F, Torab R, Goldust M. Vulvovaginitis candidiasis recurrence during pregnancy. Pak. J. Biol. Sci., 2012, 15(8): 399-402.
12. Leli C, Mencacci A, Meucci M et al. Association of pregnancy and Candida vaginal colonization in women with or without symptoms of vulvovaginitis. Minerva Ginecol., 2013, 65(3): 303-39.
13. Djukic S, Opavski N, Mijac V, Ranin L. Current knowledge of bacterial vaginosis. Srp Arh Celok Lek., 2011, 139(5-6): 402-8.
14. Larsson PG, Brandsborg E, Forsum U et al. Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses. BMC Infect Dis, 2011, 19(11): 223-25.
15. Nelson DB, Hanlon A, Nachamkin I et al. Early pregnancy changes in bacterial vaginosis-associated bacteria and preterm delivery. Paediatr Perinat Epidemiol, 2014, 28(2): 88-96.
16. Petersen EE, Genet M, Caserini M, Palmieri R. Efficacy of vitamin C vaginal tablets in the treatment of bacterial vaginosis: a randomised, double blind, placebo controlled clinical trial. Arzneimittelforschung, 2011, 61(4): 260-65.
17. Minaev N.N., Provotorova T.V. Long-term results of using the drug neo-penotran forte for the treatment of patients with bacterial vaginosis // Young Scientist. - 2015. — No. 6. — pp. 283-287. .
18. Brocklehurst P, Gordon A, Heatley E, Milan SJ. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev, 2013, 1: CD000262, pub 4.
